AXM Pharma Financials

Based on the key measurements obtained from AXM Pharma's financial statements, AXM Pharma is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.
  
Understanding current and past AXM Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AXM Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in AXM Pharma's assets may result in an increase in income on the income statement.

AXM Pharma Stock Summary

AXM Pharma, Inc. manufactures and sells over-the-counter and prescription pharmaceutical products in the Peoples Republic of China. Axm Pharma operates under Biotechnology classification in the United States and is traded on NYSEMKT Exchange.
InstrumentUSA Stock View All
ExchangeOTCCE Exchange
ISINUS0024571095
Business Address30 Wall Street,
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.axmpharma.net
Phone917 890 7067
CurrencyUSD - US Dollar

AXM Pharma Key Financial Ratios

AXM Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AXM Pharma's current stock value. Our valuation model uses many indicators to compare AXM Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AXM Pharma competition to find correlations between indicators driving AXM Pharma's intrinsic value. More Info.
AXM Pharma is rated second in profit margin category among its peers. It is number one stock in operating margin category among its peers reporting about  1.49  of Operating Margin per Profit Margin. Comparative valuation analysis is a catch-all technique that is used if you cannot value AXM Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Consideration for investing in AXM Stock

If you are still planning to invest in AXM Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AXM Pharma's history and understand the potential risks before investing.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm